📰 Abt News
Page 121 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
August 6, 2023
Metis Global Partners LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 42.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 64,295 shares of the healthcare product maker’s stock after buying an additional 19,112 shares during the period. Metis Global Partners LLC’s holdings in Abbott Laboratories were worth […]
August 6, 2023
R.M.SINCERBEAUX Capital Management LLC trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,500 shares of the healthcare product maker’s stock after selling 250 shares during the period. […]
August 5, 2023
Modera Wealth Management LLC boosted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 10,174 shares of the healthcare product maker’s stock after purchasing an additional 135 shares during the period. Modera Wealth Management LLC’s holdings in […]
August 5, 2023
Verus Financial Partners Inc. boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 8.3% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 2,012 shares of the healthcare product maker’s stock after purchasing an additional 155 shares during the period. Verus Financial Partners Inc.’s holdings […]
August 5, 2023
Bradley Foster & Sargent Inc. CT cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 346,839 shares of the healthcare product maker’s stock after selling 612 shares during the period. Bradley Foster & Sargent […]
August 5, 2023
Private Capital Advisors Inc. lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 19.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,174 shares of the healthcare product maker’s stock after selling 5,100 shares during the […]
August 5, 2023
Verus Financial Partners Inc. increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 8.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,012 shares of the healthcare product maker’s stock after buying an additional 155 shares during the period. Verus […]
August 4, 2023
Arcblock (ABT) traded up 3.5% against the dollar during the one day period ending at 19:00 PM ET on August 3rd. During the last week, Arcblock has traded down 8.2% against the dollar. Arcblock has a market capitalization of $8.02 million and $201,806.86 worth of Arcblock was traded on exchanges in the last day. One […]
August 4, 2023
Renasant Bank lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 4,433 shares of the healthcare product maker’s stock after selling 102 shares during the quarter. Renasant Bank’s holdings in Abbott Laboratories were worth $449,000 as of its most recent […]
August 4, 2023
Mawer Investment Management Ltd. lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 93.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 707,815 shares of the healthcare product maker’s stock after purchasing an additional 342,231 shares during the period. Mawer Investment Management Ltd.’s holdings in Abbott Laboratories were worth $71,673,000 […]